Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

Cosmo Advanced Materials (005070.KS) Q1 2026: Net Loss as ₩3B Interest Bill Eclipses Operating Profit, ₩120B CB Bets on Europe

Revenue recovers 7.8% year-on-year but a ₩3.0 billion interest burden runs nearly three and a half times the entire operating profit, exposing the structural gap between Cosmo's financing ambitions and its current earnings capacity.

Source: Q1 2026 Quarterly Report (분기보고서) — Filed May 2026 with DART | Standalone Financial Statements (K-IFRS) | Unit: ₩ billions

Cosmo Advanced Materials posted Q1 2026 revenue of ₩122.7 billion, up 7.8% year-on-year, yet the headline recovery conceals a deteriorating financial structure beneath it. Operating income fell 16.3% to ₩870 million, interest expense of ₩3.0 billion ran nearly three and a half times that entire operating profit, and the quarter closed with a net loss of ₩3.57 billion — a full reversal from the prior-year period's ₩1.92 billion gain. At the center of the story is the ₩120 billion five-year convertible bond issued on January 30, 2026, which simultaneously shored up the cash balance to ₩105.6 billion and reloaded the balance sheet with interest-bearing liabilities that the company's operating earnings cannot currently service. With cathode active material utilization standing at 41.3% — even under a revised capacity calculation methodology — and no new large-scale order backlog disclosed, the question investors are now asking is not whether Cosmo can raise capital, but whether the underlying business can close the gap to its cost of financing.

Balance Sheet

Asset Overview

The tripling of cash is not a product of operating strength. The ₩105.6 billion closing balance reflects ₩120 billion of CB proceeds, ₩35 billion from a concurrent rights offering, and net repayment of short-term borrowings — external inflows layered on top of each other rather than self-generated liquidity. The 47% increase in trade receivables dwarfs the 7.8% revenue growth by a wide margin, signaling a lengthening collection cycle that warrants close monitoring given the customer base's concentration in Samsung Electro-Mechanics, Samsung SDI, and LG Chem.

The inventory decline of 18.3% is the quarter's most constructive data point on the asset side. It coincides with the reversal of ₩3.6 billion in valuation allowances, indicating that low-cost cathode material stockpiles accumulated during the prior downcycle have been substantially worked through. Construction-in-progress of ₩318.7 billion — representing 39.3% of total assets — confirms the company remains in mid-CapEx cycle, with the largest capital commitment still ahead.

Liability Structure: Financial vs. Operating

Financial liabilities shifted meaningfully in character even as the absolute quantum of bank borrowings fell. Short-term borrowings declined 22.6% to ₩98.2 billion, and the ₩6 billion current portion of long-term debt outstanding at year-end was fully repaid in the quarter. Yet the ₩120 billion CB — carried at ₩98 billion on the balance sheet after bifurcating the equity-component value — pushed total interest-bearing financial liabilities from approximately ₩132.7 billion to roughly ₩196.2 billion, a 48% increase. The maturity profile has structurally lengthened in the process: bank lines mature within 12 months, but the CB does not mature until January 2031. An ₩11 billion derivative liability representing the put option embedded in the CB captures the early-redemption risk as a balance sheet line item; the accounting logic of this figure is explained in detail under Key Findings.

Operating liabilities moved in the opposite direction across the board. Trade payables contracted 40.7% to ₩33.1 billion, accrued expenses fell 25.1% to ₩7.4 billion, and other payables dropped 43.4% to ₩5.9 billion. This broad-based compression in working capital payables relative to revenue growth suggests the company deployed a portion of CB proceeds to accelerate supplier settlements, deliberately tightening the payables side of the working capital cycle ahead of further production ramp.

Capital Quality

Paid-in capital (share capital plus capital surplus) expanded 12.1% from ₩370.1 billion to ₩415.0 billion, absorbing the ₩35 billion rights offering and ₩9.85 billion in equity-component value allocated from the CB under IFRS bifurcation. Retained earnings, meanwhile, contracted from ₩94.8 billion to ₩91.2 billion as the net loss for the quarter eroded accumulated equity for the first time in recent periods. Paid-in capital now stands at 4.6 times retained earnings — a ratio that tells a straightforward structural story. Growth here is being funded externally while the business itself has not yet demonstrated sufficient earnings power to build the equity base organically. In a capital-intensive cathode materials cycle, heavy reliance on external financing is structurally inevitable; but the turn of retained earnings into decline is a qualitative signal that deserves weight alongside the headline revenue recovery.

Income Statement

Core Profitability Metrics

An operating margin below 1% is itself a statement about where the cathode active materials sector sits in the current cycle. The more consequential metric is the interest coverage ratio: ₩870 million in operating income against ₩3.0 billion in interest expense — up 83% year-on-year — yields coverage of approximately 0.3 times. The company cannot service its debt from operating earnings alone. This is not yet a liquidity crisis; the CB proceeds and rights offering have provided an ample cash runway. But it is a structural mismatch that cannot persist without either a meaningful upturn in operating margins or a structural change in the financing mix.

Financial Income and Expenses: The Quarter's Critical Variable

Financial expenses surged to ₩14.9 billion, a 333% year-on-year increase, overwhelming financial income of ₩8.9 billion and producing a net financial loss of ₩6.0 billion. The ₩14.9 billion total breaks down as: interest expense ₩3.0 billion (+83%), foreign exchange losses ₩5.57 billion, foreign currency translation losses ₩3.19 billion, futures trading losses ₩2.97 billion, and derivative instrument valuation losses ₩130 million. The CB, issued in late January with only two months remaining in the quarter, was already registering in both the interest line and the derivative liability mark-to-market. Equity-method income from associates — primarily Shandong New Powder and Cosmo Catalyst — contributed a ₩120 million gain, a marginal positive reversal from the prior year.

Cost Structure: Fixed Leverage Working Against the Business

At the gross level, the cost of revenue ratio held virtually flat at 93.8% versus 93.7% in Q1 2025, confirming that unit economics on cathode materials remain structurally compressed. With raw material and conversion costs largely fixed at current utilization levels, gross margin recovery is almost entirely a function of volume; there is little room left for cost-side mitigation.

SG&A of ₩6.74 billion rose 10.0% year-on-year against revenue growth of 7.8%, generating negative operating leverage in the period. Approximately ₩3.5 billion of the SG&A total — 52% — carries a fixed character: salaries (₩1.93 billion), retirement benefit costs (₩190 million), depreciation and amortization on tangible, intangible, and right-of-use assets (₩360 million), lease costs (₩20 million), and ongoing development expenditure charged to SG&A (₩1.02 billion). The variable component, led by service fees (₩1.79 billion, up 15%) and freight (₩450 million), also accelerated. A fresh ₩170 million bad debt provision — presumably linked to the receivables expansion noted above — added incremental pressure that had no prior-year counterpart. R&D expenditure ran at 0.83% of revenue (versus 0.86% in Q1 2025), a ratio below the typical range for cathode materials peers, though the company is simultaneously advancing both solid-state battery cathode formulations and precursor-free cathode chemistries.

Cash Flow

Operating Cash Flow: A Sharp Reversal

The swing from ₩63.9 billion of operating inflow in Q1 2025 to ₩35.2 billion of outflow in Q1 2026 is the single most striking number in the quarter. Two working capital movements explain most of it: expanding trade receivables consumed ₩28.4 billion of cash as collection cycles lengthened, and the contraction in trade payables drained a further ₩22.7 billion. Together, these two line items account for ₩51.1 billion of working capital deterioration — more than the total operating cash outflow itself, meaning that even the modest operating profit generated in the period was fully absorbed before these effects registered. Corporate income tax paid was ₩90 million; interest paid was ₩1.9 billion.

Investing Activity

Capital expenditure of ₩7.7 billion was slightly below the ₩8.8 billion deployed in Q1 2025, consistent with a measured pause ahead of the planned European line investment whose major spending is scheduled to begin from Q2 2026. Additionally, ₩2.53 billion went into fair-value-through-OCI financial assets and ₩3.1 billion into deposits and guarantee payments.

Financing and Free Cash Flow

The ₩117.6 billion financing inflow is almost entirely the CB and rights offering: ₩120 billion from the convertible bond, ₩35 billion from the equity issuance, offset by ₩28.7 billion net repayment of short-term borrowings and ₩6 billion repayment of the maturing long-term tranche. Free cash flow — operating cash flow minus capital expenditure — came in at negative ₩42.9 billion, reversing sharply from a strongly positive prior-year position. The CB buffer is substantial, but the timeline for deployment into European capacity construction runs through end-2027, meaning FCF is unlikely to turn materially positive for several quarters. The company is currently dependent on external capital to sustain operations and investment simultaneously.

Key Findings

Cathode Utilization at 41.3%: The Methodology Change Matters

Cosmo's disclosure that cathode active material utilization stood at 41.3% in Q1 2026 — production volume 2,032 tonnes against a stated capacity of 4,920 tonnes — carries a methodological footnote that makes year-on-year comparison unreliable. The company explicitly disclosed a change in its capacity calculation starting this quarter: rather than reporting total nameplate capacity across all installed production lines, it now reports the average capacity of lines actually operated. The definitional narrowing is visible in the disclosed capacity sequence: 37,320 tonnes in the 58th fiscal period, 6,480 tonnes in the 59th, and 4,920 tonnes in the current quarter — a progression that reflects accounting methodology change far more than physical equipment removal. Against full nameplate capacity, the effective utilization rate would be meaningfully lower than 41%.

Even under the narrower definition, 41% on actively operated lines confirms that Cosmo's primary downstream customers — likely Samsung SDI and LG Chem — are still working through EV battery inventory overhang. The contrast with the functional film segment is stark: MLCC release film lines ran at 90.5% utilization, driven by AI server and automotive premium demand that has no apparent correlation to the EV battery cycle.

Raw Material Divergence: Cobalt Surge vs. Lithium Softness

Cobalt prices jumped from ₩36,270 per kilogram to ₩120,179 per kilogram — a 231% increase over the comparison period — while lithium eased 7.9% to ₩23,413 per kilogram. Cosmo's high-nickel cathode orientation limits direct cobalt exposure in the current product mix, but any strategic pivot toward mid-nickel or LFP formulations to capture lower-cost EV segments would materially increase the company's vulnerability to cobalt pri